Utah Admin. Code R414-60-4 - Program Coverage
(1) Covered
outpatient drugs eligible for federal medical assistance percentages funds are
included in the pharmacy benefit; however, covered outpatient drugs may be
subject to limitations and restrictions.
(2) In accordance with Subsection
58-17b-606(4), if
a multi-source A-rated legend drug is available in the generic form, Medicaid
reimburses only for the generic form of the drug unless:
(a) reimbursing for the non-generic
brand-name legend drug will result in a financial benefit to the
state;
(b) the treating physician
demonstrates a medical necessity for dispensing the non-generic, brand-name
legend drug; or
(c) the generic
form of the drug is unavailable in the marketplace as defined in the Utah
Medicaid Pharmacy Services Provider Manual.
(3)
42 U.S.C
1396b(i)(23) requires
Medicaid prescriptions not executed electronically to be written on
tamper-resistant prescription forms as follows:
(a) tamper-resistant prescription forms must
include each of the following:
(i) one or
more industry-recognized features designed to prevent unauthorized copying of a
completed or blank prescription form;
(ii) one or more industry-recognized features
designed to prevent the erasure or modification of information written on the
prescription by the prescriber; and
(iii) one or more industry-recognized
features designed to prevent the use of counterfeit prescription
forms.
(b) Documentation
by the pharmacy of verbal confirmation of a prescription not written on a
tamper -resistant prescription form by the prescriber or the prescriber's agent
satisfies the tamper-resistant requirement. Documentation of the verbal
confirmation must include the date, time, and name of the individual who
verified the validity of the prescription.
(c) A pharmacy must maintain documentation
that a Medicaid member or authorized representative has received a prescription
for a covered outpatient drug. The documentation must clearly identify the
covered outpatient drug and the date it was received.
(i) The Division of Integrated Healthcare
shall waive the proof of delivery requirement for Non-Controlled Schedule 2
prescriptions.
(ii) In accordance
with Subsection R414-60-4(3)(c),
the proof of delivery requirement remains for Controlled Schedule 2 (CII)
medications that includes a signature or other documentation. The pharmacy
shall document member receipt as stated in Subsection
R414-60-4(3)(c).
(d) Claims for covered outpatient drugs not
dispensed to a Medicaid member or the member's authorized representative within
14 days must be reversed and any payment from Medicaid must be
returned.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.